Legislative Activity

The Climate Change Health Protection and Promotion Act of 2025 establishes a new Office of Climate Change and Health Equity within HHS to coordinate federal efforts against climate-related health threats. This office is tasked with developing a comprehensive national strategic action plan to prepare the U.S. health sector for climate impacts, with a special focus on vulnerable communities. The Act also creates a science advisory board and mandates regular expert reports to ensure the national strategy is based on the best available science and continuously updated.

The Medicaid Breast Cancer Access to Treatment Act expands Medicaid eligibility to cover certain individuals who have had breast or cervical cancer. This legislation also mandates that Medicaid coverage must include breast reconstruction surgery following a medically necessary mastectomy. These changes aim to ensure comprehensive care and remove financial barriers for cancer survivors under the program.

The Right to FDA-Approved Medicines Act guarantees individuals the right to obtain and receive information about medicines already approved by the FDA. This law preempts and overrides conflicting federal and state regulations that restrict access to or the provision of these approved drugs by healthcare providers. It establishes strong enforcement mechanisms, allowing both the Attorney General and private citizens to sue states that violate these protections.

The Medicare Breast Reconstruction Access and Information Act mandates that suppliers performing medically necessary mastectomies must inform patients about their Medicare coverage for post-mastectomy breast reconstruction. This information must be provided and documented in the patient's medical file before the surgery takes place. Failure to comply will result in Medicare withholding payment for the mastectomy procedure.

This resolution expresses the sense of Congress that extreme weather poses unique and severe threats to the health and well-being of children. It urges that solutions to address these escalating dangers must be rapidly and equitably developed and deployed with children's specific vulnerabilities in mind. The bill calls for prioritizing the physical and mental health needs of children in all future climate adaptation and air quality planning efforts.

The Stop ICE from Kidnapping U.S. Citizens Act strictly prohibits U.S. Immigration and Customs Enforcement (ICE) from using any federal funds for civil immigration enforcement activities involving U.S. citizens. Specifically, this bill bans ICE from spending money to detain or transport any citizen of the United States. This measure ensures federal funds are not used to wrongfully target or remove American citizens.

The Housing Is a Human Right Act of 2025 aims to combat homelessness and housing instability through comprehensive federal action. It establishes new funding streams and infrastructure investments to build affordable housing and provide direct support services while shifting local responses away from criminalizing poverty. Furthermore, the Act introduces new taxes on high-value real estate transactions to fund these initiatives and mandates stronger civil rights protections across federal housing and assistance programs.

The Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2025 aims to enhance cosmetic safety through targeted research into health disparities affecting communities of color and salon workers. The bill mandates improved access to safety data sheets in multiple languages for professional products and establishes two new National Resource Centers to empower these communities and workers. Finally, it brings synthetic hair braids under FDA cosmetic regulation, requiring new safety standards and labeling.

This resolution declares a health and safety emergency disproportionately affecting children due to prior administration directives that promoted fossil fuels and suppressed climate science. Congress asserts that these actions harm children's fundamental rights to life and a stable environment by worsening climate change impacts. The bill demands the current administration cease policies that increase greenhouse gases and restore access to suppressed climate research. Ultimately, it calls for aligning all energy and climate laws with the duty to protect the rights and future of young people.

The Cosmetic Hazardous Ingredient Right to Know Act of 2025 significantly updates cosmetic regulation by mandating comprehensive ingredient disclosure, especially for fragrances and flavors, on both product labels and brand owner websites. This law requires detailed, machine-readable online ingredient lists and specific hazard warnings on packaging if certain harmful chemicals are present. Importantly, this federal act preserves the authority of states to enact stricter ingredient bans or transparency requirements.

The Asunción Valdivia Heat Illness, Injury, and Fatality Prevention Act of 2025 mandates that employers protect workers from dangerous heat stress by establishing comprehensive safety standards. This Act requires the Secretary of Labor to create evidence-based rules covering engineering controls, administrative procedures, required training, and paid rest breaks to prevent heat-related illness. Furthermore, the law establishes strict enforcement mechanisms, whistleblower protections, and specific timelines for the implementation of these new federal heat protection standards.

The Cosmetic Supply Chain Transparency Act of 2025 enhances cosmetic regulation by requiring detailed ingredient and supply chain information sharing between brand owners and suppliers. This law mandates the FDA to create a public list of harmful, nonfunctional chemical traces that suppliers must eventually test for and certify. Importantly, this federal legislation preserves the right of states to enact stricter ingredient or transparency rules than those established here.

The Toxic-Free Beauty Act of 2025 establishes new federal standards for cosmetic safety by banning the intentional addition of specific harmful chemicals, such as formaldehyde and certain parabens, in products sold in the U.S. It also sets maximum allowable limits for certain contaminants like 1,4 dioxane and lead. Importantly, this federal legislation does not preempt stricter state laws regarding cosmetic ingredients. These new requirements will take effect for products shipped interstate starting January 1, 2027.

This bill amends federal law to establish strict limits and reporting requirements for donations made to Presidential Libraries and Centers. It prohibits certain restricted entities, such as lobbyists and federal contractors, from donating while a President is in office or for two years after they leave. The legislation also imposes an aggregate $10,000 lifetime donation cap per person and mandates public disclosure of all significant contributions.

The State-Based Universal Health Care Act of 2025 empowers individual states to design and implement their own comprehensive universal health coverage systems. States can apply for a federal waiver to bypass most existing federal health insurance rules, including major parts of the ACA, Medicare, and Medicaid. In exchange for waiving federal funding, the federal government will transfer equivalent funds to the state, provided the state commits to covering at least 95% of its residents within five years and maintains budget neutrality for the federal government.

The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025 aims to significantly increase federal research, public education, and provider awareness regarding uterine fibroids. The bill mandates expanded research coordination across federal agencies and authorizes funding to study the condition, which disproportionately affects minority women. It also requires the creation of public awareness campaigns detailing non-hysterectomy treatment options and mandates data collection on Medicaid/CHIP spending for fibroid treatments.

The Uterine Cancer Study Act of 2025 mandates a comprehensive federal study to investigate the potential link between the use of chemical hair straighteners and the risk of developing uterine cancer. This research must specifically examine disparities in cancer rates among women of color. The study will ultimately recommend whether the FDA should require additional safety testing for these hair products.

The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 aims to improve the detection and treatment of uterine fibroids. It mandates federal research to develop evidence-based early detection strategies and establishes grant programs for states to fund screening, education, and intervention services, prioritizing vulnerable populations. Furthermore, the bill allocates funding for research into pain management related to fibroid surgery and other uterine conditions.

This Act authorizes the Secretary of the Treasury to mint and sell special commemorative coins for the 2028 Los Angeles Olympic and Paralympic Games and the 2034 Salt Lake City Winter Olympic and Paralympic Games. The coins will feature designs celebrating American athletes and the Games themselves. All surcharges collected from the sale of these coins will be directed to the respective organizing committees to help fund the events and related youth sports programs. The entire program must be conducted at no cost to the U.S. Government.

This resolution supports the designation of July as Uterine Fibroids Awareness Month to highlight the significant health impact of these common growths on women. It recognizes the disproportionate burden of fibroids on Black and Hispanic women and calls for increased research and improved treatment options. The bill encourages the President to issue a proclamation supporting national awareness activities throughout July.